📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Administration of mesenchymal stem cells during ECMO results in a rapid decline in oxygenator performance. (2019)

First Author: Millar JE

Attributed to: A GMP cell therapy facility to test cell based therapies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/thoraxjnl-2017-211439

PubMed Identifier: 29622695

Publication URI: http://europepmc.org/abstract/MED/29622695

Type: Journal Article/Review

Volume: 74

Parent Publication: Thorax

Issue: 2

ISSN: 0040-6376